Advertisement
UK markets close in 6 hours 21 minutes

  • FTSE 100

    8,098.42
    +58.04 (+0.72%)
     

  • FTSE 250

    19,724.90
    +5.53 (+0.03%)
     

  • AIM

    754.93
    +0.24 (+0.03%)
     

  • GBP/EUR

    1.1672
    +0.0027 (+0.23%)
     

  • GBP/USD

    1.2520
    +0.0058 (+0.46%)
     

  • Bitcoin GBP

    51,196.00
    -1,863.26 (-3.51%)
     

  • CMC Crypto 200

    1,359.18
    -23.39 (-1.69%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.96
    +0.15 (+0.18%)
     

  • GOLD FUTURES

    2,339.00
    +0.60 (+0.03%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    18,002.11
    -86.59 (-0.48%)
     

  • CAC 40

    8,060.80
    -31.06 (-0.38%)
     
Property:

How to sell your home

Top tips from property investors

Bavarian Nordic sells monkeypox vaccines to Canada

Reuters
A laboratory of the vaccine company Bavarian Nordic, in Martinsried near Munich

COPENHAGEN (Reuters) - Danish biotechnology company Bavarian Nordic said on Tuesday it had signed a $56 million contract with Canada for its smallpox vaccine, which is also approved for use against monkeypox in the country, with deliveries starting next year.

"In parallel, Bavarian Nordic continues to secure contracts with other countries, including Denmark, but also countries outside Europe, to supply the vaccine to mitigate the current monkeypox outbreak", said the firm.

Bavarian will also host an investor call later on Tuesday at 1500 CET (1300 GMT).

(Reporting by Stine Jacobsen, editing by Terje Solsvik)